We're excited to share Psylo's partnership with Dr Nick Everett, from the University of Sydney’s Brain and Mind Centre, to pioneer innovative treatments for neuropsychiatric disorders by leveraging advanced artificial intelligence technologies.
This collaboration combines our cutting-edge artificial intelligence platform with the university’s world-class research expertise. Our goal is to accelerate the development of mental health treatments that are not only safer and more effective but also accessible to those in need.
Dr Nick Everett – an NHMRC Emerging Leader, Research Fellow at the University’s School of Psychology and an expert in behavioural neuroscience – has been awarded a partnership grant by the Brain and Mind Centre to lead this initiative.
We are privileged to work alongside Dr Everett, who has developed an innovative machine-learning-guided behavioral analysis platform. Psylo will use this powerful technology to enhance our drug development process, increasing both capacity and efficiency.
“By combining our machine-learning models with Psylo's cutting-edge platform, we aim to develop more effective and safer treatments for mental health conditions, at a pace faster than previously possible," said Dr Nick Everett.
Psylo's co-founder and CSO, 💊 Sam Banister, added, “Our proprietary computational platform has successfully optimised next-generation drug candidates that retain the therapeutic benefits of natural psychedelics in preclinical models. The expertise provided by Dr Everett and the University will be invaluable in accelerating the translation of these compounds into viable treatments for patients."
🧪 Joshua Ismin, Psylo's co-founder and CEO, commented, “The treatments we are developing could redefine how we treat depression, anxiety, and other central nervous system disorders. Through this partnership, we can use machine-learning approaches to expedite the development of these promising therapeutics to address this tremendous unmet need.”
👏 Join us in celebrating this partnership, set to revolutionize the treatment of central nervous system disorders.
👀 Read the full story here: https://lnkd.in/gt3gyRQ3
#Psylo #USYD #Biotech #MentalHealth #CNS #5HT2A